<SEC-DOCUMENT>0001104659-20-107789-index.html : 20200923 <SEC-HEADER>0001104659-20-107789.hdr.sgml : 20200923 <ACCEPTANCE-DATETIME>20200923155602 ACCESSION NUMBER: 0001104659-20-107789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200922 FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Jeffrey Allen CENTRAL INDEX KEY: 0001500210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 811-06565 FILM NUMBER: 201192101 MAIL ADDRESS: STREET 1: KING PHARMACEUTICALS, INC. STREET 2: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEKLA LIFE SCIENCES INVESTORS CENTRAL INDEX KEY: 0000884121 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 043147016 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6177728515 MAIL ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: H&Q LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 19920929 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>a4.xml <DESCRIPTION>4 <TEXT> Document 1 - file: a4.html
Document 1 - RAW XML: a4.xml
</DOCUMENT> </SEC-DOCUMENT>